Neonatal Abstinence Syndrome due to In-utero Exposure to Gabapentin: A Case Report
Alyssa Brzenski, Mark Greenberg
International Journal of Medical and Pharmaceutical Case Reports · pp. 116–120 · Published 15 Apr 2015
10.9734/IJMPCR/2015/17253Abstract
We report the case of a neonate who likely developed symptoms of Neonatal Abstinence Syndrome after in-utero exposure to gabapentin for treatment of maternal chronic pain. The neonate developed symptoms of hypertonicity, tremor, and poor feeding twelve hours after delivery. Although the neonate wasbriefly exposed to the benzodiazepine alprazolam and the opioid oxycodone, the withdrawal symptoms were not characteristic of opioid or benzodiazepine withdrawal, such as hyperphagia, vomiting and loose stools. Due to a high suspicion of gabapentin withdrawal, the neonate was successfully treated with gabapentin and clonidine. Neonatal abstinence syndrome from gabapentin has been reported in the past [1] but in each of the reports the diagnosis has been questioned due to the prolonged maternal use of multiple other agents. We present a case with distinctly different symptoms of NAS after maternal exposure to gabapentin with discussion of the diagnosis, treatment and management of these neonates.
References (19)
- 1 Gabapentin for the Symptomatic Treatment of Painful Neuropathy in Patients With Diabetes Mellitus A Randomized Controlled Trial [DOI]
- 2 Neonatal abstinence syndrome: assessment and management.
- 3 Neonatal Abstinence Syndrome After In Utero Exposure to Selective Serotonin Reuptake Inhibitors in Term Infants [DOI]
- 4 Newer-Generation Antiepileptic Drugs and the Risk of Major Birth Defects [DOI]
- 5 The Analgesic Effects of Gabapentin After Total Abdominal Hysterectomy [DOI]
- 6 Gabapentin in the treatment of neuropathic pain [DOI]
- 7 Management of neonatal abstinence syndrome in neonatal intensive care units: a national survey [DOI]
- 8 Analgesic Effects of Gabapentin after Spinal Surgery [DOI]
- 9 Gabapentin exposure in human pregnancy: results from the Gabapentin Pregnancy Registry [DOI]
- 10 Pregnancy outcomes following gabapentin use [DOI]
- 11 Management of neonatal abstinence syndrome: a national survey and review of practice [DOI]
- 12 Single‐Dose Gabapentin Pharmacokinetics and Safety in Healthy Infants and Children [DOI]
- 13 Importance of Gabapentin Dose in Treatment of Opioid Withdrawal [DOI]
- 14 Use of gabapentin in the treatment of childhood reflex sympathetic dystrophy [DOI]
- 15 Treatment of Pain With Gabapentin in a Neonate [DOI]
- 16 Gabapentin in the management of reflex sympathetic dystrophy [DOI]
- 17 Gabapentin Blocks and Reverses Antinociceptive Morphine Tolerance in the Rat Paw-pressure and Tail-flick Tests [DOI]
- 18 Population pharmacokinetics of gabapentin in infants and children [DOI]
- 19 Effect of add‐on gabapentin on opioid withdrawal symptoms in opium‐dependent patients [DOI]
Cited by 4
Merav Cohen‐Israel, Itai Berger, Einat Y. Martonovich · British Journal of Clinical Pharmacology · 2017
Hibo H. Abdi, Nathalie L. Maitre, Kristen L. Benninger · Pediatric Neurology · 2019
Showing 2 of 4 known citations — external sources report more than can currently be individually listed.
Related research
- Increase in Citrate and KCl Consumption during Morphine Withdrawal Period is Associated with Reduced Levels of Zinc and Brain-derived Neurotrophic Factor, and Poor Neurogenesis in Male Isolated Rats — shares topic coverage
- Awareness of Hygiene and Safety Practices on Raw Milk Produced and Consumed in Kiambu County, Kenya — shares topic coverage
- Role of Hippocampal Neurogenesis in Regulation of Feeding Behavior during Withdrawal Period in Socialized and Isolated Rats — shares topic coverage
- Evidence of Regeneration of Testicular and Epididymal Tissue Structure and Function Following Withdrawal from Sub-chronic Khat Exposure: Studies in the Rabbit Animal Model — shares topic coverage
- Withholding and Withdrawal of Life-Sustaining Treatment in Palliative Care: Ethical, Legal, and Cultural Perspectives in Indonesia — shares topic coverage
Article metrics
Real usage data collected on this platform.
34
Page views
0
PDF downloads
5
Outbound clicks
4
Citations
Views over time
Views by country
Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".
Traffic sources
Referring site, by host.
Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.